We produced chicken/mouse chimeric mAb against human GPC1, which cross-reacts with mGPC1, and demonstrated marked tumor growth inhibition by anti-GPC1 mAb in SCID mice xenografted with GPC1-positive TE14 cells via ADCC and CDC activity. Here, GPC1 is linked to neoplasm.